Showing 1 to 2 of 2 results


UnitedHealth's Earnings Miss Triggers Market Downturn
UnitedHealth Group's stock plummeted 22.4% Thursday after missing earnings targets, dragging the Dow down 1.3%; a federal judge ruled against Google on antitrust charges; and the IMF lowered its global growth forecast amid trade uncertainties.
UnitedHealth's Earnings Miss Triggers Market Downturn
UnitedHealth Group's stock plummeted 22.4% Thursday after missing earnings targets, dragging the Dow down 1.3%; a federal judge ruled against Google on antitrust charges; and the IMF lowered its global growth forecast amid trade uncertainties.
Progress
56% Bias Score

FDA Approves Precision Neuroscience Brain Implant Amidst Reported Regulatory Slowdowns
The FDA approved Precision Neuroscience's minimally invasive brain implant designed to help paralyzed patients regain function, despite reports of slowed drug development under the Trump administration.

FDA Approves Precision Neuroscience Brain Implant Amidst Reported Regulatory Slowdowns
The FDA approved Precision Neuroscience's minimally invasive brain implant designed to help paralyzed patients regain function, despite reports of slowed drug development under the Trump administration.
Progress
44% Bias Score
Showing 1 to 2 of 2 results